Your browser doesn't support javascript.
loading
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial.
Kievit, H; Muntinghe-Wagenaar, M B; Hijmering-Kappelle, L B M; Hiddinga, B I; Ubbels, J F; Wijsman, R; Slingers, G; de Vries, R; Groen, H J M; Kerstjens, H A M; van der Wekken, A J; Hiltermann, T J N.
Afiliación
  • Kievit H; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Muntinghe-Wagenaar MB; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Hijmering-Kappelle LBM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Hiddinga BI; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Ubbels JF; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Wijsman R; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Slingers G; Breathomix BV, Leiden, the Netherlands.
  • de Vries R; Breathomix BV, Leiden, the Netherlands.
  • Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Kerstjens HAM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: t.j.n.hiltermann@umcg.nl.
Lung Cancer ; 178: 96-102, 2023 04.
Article en En | MEDLINE | ID: mdl-36806899

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Irlanda